Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (QGEN)
NYSE:QGEN
Earnings Data
Report Date
Aug 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.6Last Year’s EPS
0.57Same Quarter Last Year
Moderate Buy
Based on 13 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2025
|% Change Since: 0.16%
|Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment|Positive
Qiagen delivered a strong start to 2025, exceeding expectations for net sales and earnings. Key product lines showed robust growth, and profitability improved significantly. While challenges remain in the China market and cautious customer spending, the company reaffirmed its full-year outlook and expanded shareholder return options, indicating confidence in its strategy and execution.Company Guidance
In the Q1 2025 earnings call, Qiagen reported exceeding their outlook with net sales of $483 million, reflecting a 7% increase at constant exchange rates (CER) compared to Q1 2024. Adjusted diluted earnings per share were $0.50 at CER, surpassing the expected minimum of $0.50. The company reaffirmed its full-year 2025 outlook, projecting around 4% sales growth at CER, and upgraded its adjusted earnings per share target to approximately $2.35 at CER, up $0.07 from the initial guidance. Key growth drivers included QIAstat's double-digit sales increase due to new panel launches, QuantiFERON's strong performance with double-digit sales growth, and the momentum in QIAcuity's digital PCR platform. Qiagen also highlighted its strategic initiatives, including the introduction of a cash dividend and a proposed $500 million synthetic share repurchase, as part of its goal to return at least $1 billion to shareholders by 2028.Exceeded Q1 2025 Outlook
Qiagen delivered net sales of $483 million, representing a 7% increase at constant exchange rates (CER) compared to Q1 2024. Adjusted diluted earnings per share were $0.50, exceeding the outlook for at least $0.50.
Strong Performance of Key Products
QIAstat achieved double-digit sales growth, QuantiFERON tuberculosis test delivered another strong quarter of double-digit sales growth, and QIAcuity digital PCR platform continued to build momentum in high-growth fields.
Increased Profitability
Adjusted operating income margin rose to 29.8% of sales, up more than four percentage points from Q1 2024, driven by a favorable shift towards consumables and bioinformatics solutions.
Reaffirmed Full Year 2025 Outlook
Qiagen expects around 4% sales growth at CER, with an upgraded target for adjusted earnings per share of about $2.35, up $0.07 from the initial outlook for the year.
Expansion of Shareholder Returns
Introduction of an annual cash dividend and proposal for a synthetic share repurchase of up to $500 million for consideration over an 18-month period.
---
QGEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
QGEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2025 | $42.63 | $42.16 | -1.10% |
Feb 05, 2025 | $43.80 | $42.44 | -3.11% |
Nov 06, 2024 | $43.86 | $44.14 | +0.64% |
Jul 31, 2024 | $44.48 | $45.79 | +2.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Qiagen NV (QGEN) report earnings?
Qiagen NV (QGEN) is schdueled to report earning on Aug 12, 2025, TBA Not Confirmed.
What is Qiagen NV (QGEN) earnings time?
Qiagen NV (QGEN) earnings time is at Aug 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is QGEN EPS forecast?
QGEN EPS forecast for the fiscal quarter 2025 (Q2) is 0.6.
---